Abstract
This study aims to elucidate the mechanisms of Wnt/β-catenin signaling pathway in the development of preeclampsia (PE). The mRNA levels of Wnt1, β-catenin, c-myc and cyclinD1 were determined by real-time PCR in the placentas. Moreover, the expression levels of Wnt1, β-catenin, Dickkopf-1 (DKK1) and glycogen synthase kinase 3β (GSK-3β) proteins were detected by Western blot. Immunohistochemistry was used in placental tissue microarray to localize the expression of Wnt1, β-catenin, DKK1 proteins in the placentas of two groups. Compared with the control placentas, the mRNA levels of Wnt1, β-catenin, c-myc and cyclinD1 were decreased in the severe preeclamptic placentas. The Western blot results showed that the expression levels of Wnt1, β-catenin, and GSK-3β proteins were significantly elevated in the control group, while the expression level of DKK1 was significantly decreased. In addition, the staining intensity of Wnt1, β-catenin were weaker in the placentas of the severe PE group while the staining intensity of DKK1 was significantly stronger in the placentas of the severe PE group. Wnt/β-catenin signaling pathway may play a significant role in the pathogenesis of PE by regulating the invasion and proliferation of trophoblast.
Similar content being viewed by others
Change history
29 November 2021
A Correction to this paper has been published: https://doi.org/10.1007/s10735-021-10043-9
References
Ananth CV, Keyes KM, Wapner RJ (2013) Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 347:1–9. https://doi.org/10.1136/bmj.f6564
Committee on Obstetric Practice A (2002) Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99(2):347–365
Goldman-Wohl D, Yagel S (2002) Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Mol Cell Endocrinol 187:233–238. https://doi.org/10.1016/S0303-7207(01)00687-6
Herzog EM, Eggink AJ, Reijnierse A et al (2017) Impact of early- and late-onset preeclampsia on features of placental and newborn vascular health. Placenta 49:72–79. https://doi.org/10.1016/j.placenta.2016.11.014
Hubel CA, Wallukat G, Wolf M et al (2007) Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49:612–617
Kaufmann P, Black S, Huppertz B (2003) Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69:1–7. https://doi.org/10.1095/biolreprod.102.014977
Kestler HA, Kuhl M (2008) From individual Wnt pathways towards a Wnt signalling network. Philos Trans R Soc B Biol Sci 363:1333–1347. https://doi.org/10.1098/rstb.2007.2251
Kumar P, Luo Y, Tudela C et al (2013) The c-Myc-regulated microRNA-17 92 (miR-17 92) and miR-106a 363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol 33:1782–1796. https://doi.org/10.1128/MCB.01228-12
Liao DJ, Thakur A, Wu J et al (2007) Perspectives on c-Myc, cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy. Crit Rev Oncog 13:93–158. https://doi.org/10.1615/CritRevOncog.v13.i2.10
MacDonald BT, Tamai K, He X (2010) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Biol 17:9–26. https://doi.org/10.1016/j.devcel.2009.06.016.
Mol BWJ, Roberts CT, Thangaratinam S et al (2016) Pre-eclampsia. Lancet 387:999–1011. https://doi.org/10.1016/S0140-6736(15)00070-7
Pollheimer J, Loregger T, Sonderegger S et al (2006) Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 168:1134–1147. https://doi.org/10.2353/ajpath.2006.050686
Rao H, Bai Y, Zhang F et al (2018) The role of SATB1 in HTR8/SVneo cells and pathological mechanism of preeclampsia. J Matern Fetal Neonatal Med 16:1–10. https://doi.org/10.1080/14767058.2018.1425387
Redman CWG, Sacks GP, Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 180:499–506. https://doi.org/10.1016/S0002-9378(99)70239-5
Redman CW, Sargent IL, Staff AC (2014) IFPA senior award lecture: making sense of pre-eclampsia—two placental causes of preeclampsia? Placenta 35:S20–S25. https://doi.org/10.1016/j.placenta.2013.12.008
Romero R, Chaiworapongsa T (2013) Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest 123:2775–2777. https://doi.org/10.1172/JCI70431
Sabai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365:785–799. https://doi.org/10.1016/S0140-6736(05)17987-2
Sonderegger S, Husslein H, Leisser C, Knöfler M (2007) Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 28:1–12. https://doi.org/10.1016/j.placenta.2006.11.003
Tranquilli AL, Landi B, Giannubilo SR, Sibai BM (2012) Preeclampsia: no longer solely a pregnancy disease. Pregnancy Hypertens 2:350–357. https://doi.org/10.1016/j.preghy.2012.05.006
Tulac S, Nayak NR, Kao LC et al (2003) Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 88:3860–3866. https://doi.org/10.1210/jc.2003-030494
Valensise H, Vasapollo B, Gagliardi G, Novelli GP (2008) Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 52:873–880. https://doi.org/10.1161/HYPERTENSIONAHA.108.117358
Valenta T, Hausmann G, Basler K (2012) The many faces and functions of Î 2-catenin. EMBO J 31:2714–2736. https://doi.org/10.1038/emboj.2012.150
Von Dadelszen P, Magee LA, Roberts JM (2003) Subclassification of preeclampsia. Hypertens Pregnancy 22:143–148. https://doi.org/10.1081/PRG-120021060
Zhang Z, Li H, Zhang L et al (2013a) Differential expression of beta-catenin and dickkopf-1 in the third trimester placentas from normal and preeclamptic pregnancies: a comparative study. Reprod Biol Endocrinol 4:17. https://doi.org/10.1186/1477-7827-11-17
Zhang Z, Zhang L, Zhang L et al (2013b) Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia. Reprod Sci 20:981–989. https://doi.org/10.1177/1933719112472740
Zhang Z, Wang X, Zhang L et al (2017) Wnt/β-catenin signaling pathway in trophoblasts and abnormal activation in preeclampsia (Review). Mol Med Rep 16:1007–1013. https://doi.org/10.3892/mmr.2017.6718
Zhang Z, Wang X, Wang J, Zhang L (2018) The decreased expression of Stat3 and p-Stat3 in preeclampsia-like rat placenta. J Mol Histol 49:175–183. https://doi.org/10.1007/s10735-018-9757-4
Zhu L, Zhang Z, Zhang L et al (2015) HMGB1-RAGE signaling pathway in severe preeclampsia. Placenta 36:1148–1152. https://doi.org/10.1016/j.placenta.2015.08.006
Acknowledgements
The present study was supported by the National Natural Science Foundation (Grant Number 81501285).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has any conflict of interest.
Rights and permissions
About this article
Cite this article
Wang, X., Zhang, Z., Zeng, X. et al. Wnt/β-catenin signaling pathway in severe preeclampsia. J Mol Hist 49, 317–327 (2018). https://doi.org/10.1007/s10735-018-9770-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-018-9770-7